Q4 2018 Genocea Biosciences Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Genocea Biosciences Fourth Quarter 2018 Financial Results Conference Call. (Operator Instructions) As a reminder, today's conference may be recorded.
I would now like to turn the call over to Paul Arndt, Managing Director, LifeSci Advisors. Sir, please begin.
Thank you, Mark, and good morning, everyone. This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available at genocea.com, under the Investor Relations tab.
During the call today, Chip Clark, President and Chief Executive officer, will provide a corporate update and review the financial results. After his prepared remarks, we will open up the call to Q&A, and Chip; Jessica Flechtner, Genocea's Chief Scientific Officer; and Tom Davis, Genocea's Chief Medical Officer, will then be available to answer your questions.
Before we begin, I would like to remind everyone that statements made during this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
